ASCO Study Shows Drug Afinitor ® Novartis first to shrink SEGA brain tumors in children and adults with tuberous … Novartis Pharmaceuticals Corporation announced today that the results of a Phase II study show Afinitor ® tablets is the first drug in a clinical trial to reduce the size of astrocytomas subependymal giant cell, benign tumors of the brain associated with tuberous sclerosis.
911 or 999 AJ Hilder Ambulances and the skin rash experience